Principal Investigator
Stacie M. Jones, M.D., director of the Arkansas Children’s food allergy program at Arkansas Children’s Research Institute (ACRI), interim chair of rheumatology at Arkansas Children's Hospital and professor of pediatrics at the University of Arkansas for Medical Sciences (UAMS).
"Our collaborative work within the Consortium for Food Allergy Research has been a tremendous opportunity for almost two decades for Arkansas Children’s. We are on the forefront of discovery in the field while providing innovative treatments to our patients and advancing our understanding of food allergy, mechanisms of disease and future targets for therapeutic intervention and disease prevention. This research will continue to impact patients and families living with food allergy."
Principal Investigator
Aravindhan Veerapandiyan, M.D. (Dr. Panda), is a pediatric neurologist at Arkansas Children’s Hospital (ACH) and an assistant professor of pediatrics at the University of Arkansas for Medical Sciences (UAMS). He is director of the comprehensive neuromuscular program and the Parent Project Muscular Dystrophy Certified Duchenne Care Center, and co-director of the Pediatric Muscular Dystrophy Association Care Center, all at ACH.
"There is still unmet need for boys with DMD. Though available treatments such as corticosteroids and newer treatments, such as exon-skipping therapies, can slow down the disease process, no available therapy can halt the condition’s progression, or, more optimistically, reverse it. These cutting-edge research therapies have the potential to impact the trajectory of the disease and improve the life span and quality of life for boys with DMD and their families."
Principal Investigator
Tamara T. Perry, M.D., FAAP, FAAAAI, is a pediatric allergist and immunologist at Arkansas Children’s Hospital (ACH) and a professor of pediatrics and chief of the allergy and immunology division at the University of Arkansas for Medical Sciences (UAMS). She holds the Dr. and Mrs. Leeman King endowed chair in pediatric allergy, is a researcher at Arkansas Children’s Hospital Research Institute (ACRI) and medical director of telehealth at ACH.
"Guidelines-based asthma care has significantly and consistently proven to improve asthma outcomes, yet these well-established guidelines have not fully translated to the community. This is particularly problematic for high-risk populations such as adolescents. The project promotes guidelines-based asthma self-management and encourages medication adherence that fits with societal trends and preferences of today’s adolescents through the use of a smartphone-based application. Should the project prove successful in reducing morbidity and improving the health of adolescent children with asthma, it has the potential to serve as a model for improved asthma care in other high-risk populations and for other chronic diseases."
Principal Investigator
Jessica N. Snowden, M.D., M.S., MHPTT, is vice-chair for research in the department of pediatrics and associate director of clinical and translational research at Arkansas Children’s Research Institute (ACRI) and executive associate dean of research, chief of pediatric infectious diseases and professor of pediatrics at the University of Arkansas for Medical Sciences (UAMS). She holds the Horace C. Cabe endowed chair in pediatric infectious diseases. She is the co-principal investigator of the IDeA States Pediatric Clinical Trial Network’s Data Coordinating and Operations Center.
"Children and families in rural states like Arkansas deserve the opportunity to participate in high quality clinical trials, so that they have access to cutting-edge care and so that we can identify solutions to the issues most relevant for families that are often missed in clinical research."
Español 
Cookie Settings 
Accessibility